James Bligh - Interim CFO, Director at Conduit Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CFO, Director
Stock Symbol
CDT, CDTTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Bligh since 12/22/2023

Holdings reported by James Bligh for Conduit Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 1.89M $174K $0.09 Nov 18, 2024 Direct Common Stock
Common Stock 37.3K $9.63K $0.26 Jun 11, 2024 Direct

Transactions reported by James Bligh for Conduit Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.